VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
Apon Medical Invests in BCIFlex — China's First 100+ Channel Invasive BCI Clinical Trial Launched
Apon Medical Invests in BCIFlex — China's First 100+ Channel Invasive BCI Clinical Trial Launched
May 20, 2026 18:35 CST Updated 18:51
Share:
BCIFlex
Invasive High-Throughput Ultra-Thin Flexible Brain-Computer Interface System Developer